Hadassah

Hadassah Researchers Discover Gene that Compromises Respiratory System

Wednesday, Apr 3 2013

Researchers at the Hadassah University Medical Center have discovered the gene that causes primary ciliary dyskinesia (PCD), a rare condition that compromises the functioning of the cilia, the minute protective hairs in the respiratory system, thereby resulting in repeated lung infections, sinusitis, frequent ear infections, and fertility problems. In about half of the cases, the mutation also causes organs to develop in "mirror image" of one another, so that, for example, the heart develops on the right side of the chest instead of on the left, while the liver grows on the left and the stomach and spleen on the right.

Prof. Eitan Kerem, head of Pediatrics at Hadassah, and Prof. Orly Elpeleg, head of the Department of Genetic and Metabolic Diseases, along with Dr. David Shoseyov and Dr. Malena Cohen discovered the gene by studying five children from two different families who suffer from PCD. Three of the children affected suffer from the transposition of organs. According to medical estimates, the condition occurs in one out of 15,000 births, but the Hadassah researchers believe that PCD is actually more prevalent, though not always diagnosed.

Read more about it in The Jerusalem Post>>

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Sep 23 2016

2016 Graduates from 19 Countries Celebrate Hadassah’s IMPH Program

Singing "It's a Wonderful Country" in Hebrew, wearing their native dress, the members of the 41st International Master of Public Health (IMPH) program of the Hadassah-Hebrew University Braun School of Public Health and Community Medicine celebrated their graduation.

READ MORE ›
alt_text

Monday, Sep 19 2016

Hadassah Hospital Treats Terror Victims After Stabbing Attacks

This last week has brought a burst of terror attacks.

READ MORE ›
alt_text

Thursday, Sep 15 2016

“Stunning Results” Continue with Hadassah’s Stem Cell Treatment to Reverse MS

The Hadassah Medical Center is continuing to receive positive findings with its Phase II clinical trial using its unique stem cell approach to stop the progression and reversing the disabilities of multiple sclerosis.

READ MORE ›
alt_text

Thursday, Sep 15 2016

2012 Hadassah Stage-Four Melanoma Patient Thankfully Healthy

"Doctors in Florida who pronounced me ‘soon-dead’ can't believe that I'm healthy today,” said Hadassah melanoma patient Stewart Greenberg.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More